Antioxidant treatment ameliorates phenotypic features of SMC1A-mutated Cornelia de Lange syndrome in vitro and in vivo. [electronic resource]
- Human molecular genetics 09 2018
- 3002-3011 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1460-2083
10.1093/hmg/ddy203 doi
Animals Antioxidants--pharmacology Biomarkers--analysis Cell Cycle Proteins--genetics Chromosomal Proteins, Non-Histone--genetics De Lange Syndrome--drug therapy Gene Expression Profiling Gene Expression Regulation--drug effects Genomic Instability Humans In Vitro Techniques Mutation Oxidative Stress--drug effects Zebrafish--genetics Structural Maintenance of Chromosome Protein 1